Medical, Pharmaceuticals, Biotech & Healthcare · Corporate Naming Intelligence

Hong Kong Biotech & Genomics Corporate Directory

100 Registered Entities

86HC Statutory Naming & Admittance Essence

Hong Kong represents Asia's largest biotech capital hub. Due diligence audits drug pipeline IP, clinical trial status, and Chapter 18A eligibility.

Statutory Basis & Admittance

Legal Reference: HKEX Main Board Listing Rules Chapter 18A (Pre-revenue Biotech)

Regulatory Tier: Standard Corporate Title

Due Diligence & Verification Focus

Inspect clinical trial filings, PCT patent portfolio, and HKEX Chapter 18A biotech listing prerequisites.

Statutory Regulatory Authority

Standard corporate entity title with no single mandatory licence court. Review annual returns for verified business activities.

Status: All Live Dissolved

Showing 41 - 60 of 100

Corporate Name	CR Number	Date of Inc.	Status	Action
香港泊奧生物科技有限公司 Hong kong Boao Biological Technology Limited	2385246	2016-06-02	Live	View Dossier
烏克蘭干細胞中心中國有限公司 Ukraine Stem Cell Co., Limited	2684486	2018-04-20	Dissolved	View Dossier
香港洪潤堂生物科技國際集團有限公司 HongKong HongRunTang Biotechnology International Group (HK) Co., Limited	2546130	2017-06-16	Dissolved	View Dossier
滙駿基因有限公司 VG DNA LIMITED	2530261	2017-04-26	Dissolved	View Dossier
基因港控股有限公司 GeneHarbor Holding Limited	F0029667	2021-07-15	Ceased Place of Business	View Dossier
韓國韓佳人生物科技國際控股有限公司 KOREA HANGAIN BIOTECH INT'L HOLDINGS LIMITED	2456794	2016-11-28	Dissolved	View Dossier
香港清宮堂(國際)生物科技有限公司 HONGKONG QGT (INTERNATIONAL) BIOLOGICAL TECHNOLOGY LIMITED	2423649	2016-09-05	Dissolved	View Dossier
香港修身坊生物科技有限公司 HONG KONG XIU SHEN FANG BIOLOGICAL SCIENCE AND TECHNOLOGY COMPANY LIMITED	2428302	2016-09-15	Dissolved	View Dossier
香港琢顏生物科技股份有限公司 HK CARVE Y BIOTECHNOLOGY CO., LIMITED	2404540	2016-07-18	Dissolved	View Dossier
香港中德貝爾(國際)生物科技有限公司 HK ZHONGDE BEIER (INTERNATIONAL) BIOLOGICAL TECHNOLOGY LIMITED	2403499	2016-07-15	Dissolved	View Dossier
香港尚優生物科技有限公司 Hong Kong Shangyou Biological Technology Co., Limited	2404861	2016-07-19	Dissolved	View Dossier
香港媚爾盈國際生物科技有限公司 HK MEI SURPLUS INTERNATIONAL BIOLOGICAL TECHNOLOGY CO., LIMITED	2399867	2016-07-07	Dissolved	View Dossier
德高貝登生物科技有限公司 JCDecaux (Hong Kong) Biotechnology Co., Limited	2391434	2016-06-17	Dissolved	View Dossier
香港晴軒國際生物科技有限公司 HONG KONG QINGXUAN INTERNATIONAL BIOLOGICAL TECHNOLOGY CO., LIMITED	2388611	2016-06-10	Dissolved	View Dossier
香港斯菲爾德生物科技有限公司 HONG KONG SIFEI ERDE BIOLOGICAL TECHNOLOGY CO., LIMITED	2379504	2016-05-20	Dissolved	View Dossier
臺灣東星生物科技控股有限公司 Taiwan East Star Biotech Holdings Limited	2371553	2016-05-04	Dissolved	View Dossier
香港玫莉泉國際生物科技有限公司 HK MEYLEEQU INT'L BIOTECH LIMITED	2360734	2016-04-13	Dissolved	View Dossier
香港格通電信有限公司 CELL AIR TELECOM (HK) LIMITED	2282680	2015-09-04	Dissolved	View Dossier
博龍生物科技有限公司 BARRON BIOTECHNOLOGY LIMITED	2287293	2015-09-17	Dissolved	View Dossier
滋仁堂(香港)生物科技有限公司 ZIRENTANG (HK) BIOLOGICAL TECHNOLOGY CO., LIMITED	2289191	2015-09-22	Dissolved	View Dossier

1 2 3 4 5

Frequently Asked Questions on Hong Kong "Biotech & Genomics" Entities

Q1: What are the statutory requirements for incorporating a "Biotech & Genomics" entity in Hong Kong?

A: Hong Kong represents Asia's largest biotech capital hub. Due diligence audits drug pipeline IP, clinical trial status, and Chapter 18A eligibility.

Q2: How to conduct anti-fraud due diligence on "Biotech & Genomics" entities before business cooperation?

A: Inspect clinical trial filings, PCT patent portfolio, and HKEX Chapter 18A biotech listing prerequisites. In addition, it is strongly advised to inspect the latest Annual Return and Certified True Copy (CTC) of the Business Registration Certificate.

Q3: If a "Biotech & Genomics" entity shows status "Dissolved", does it still hold due diligence value?

A: It retains significant legal verification and historical credit tracing value. For dissolved entities with historical litigation, debt disputes, or trademark squatting, historical directors registers, Articles of Association, and official winding-up dossiers remain accessible via 86hc.